ACSL4 and familial dilated cardiomyopathy: Nicorandil, Astragaloside IV, and Curcumin demonstrate potential therapeutic effects in alleviating cardiac microvascular ferroptosis in DCM through various signaling pathways, including the mitochondria‐localized AMPK‐Parkin‐ACSL4 pathway, CD36‐mediated ferroptosis downregulation, and the Nrf2 pathway, respectively [72, 79, 80].